Cancer Therapy Based on Oral Bacteria Gets FDA Approval for Clinical Trials
A company founded by Rutgers School of Dental Medicine (RSDM) researcher Scott Kachlany, PhD, has received US Food and Drug Administration (FDA) approval.
Industry News
Industry News
Dental Professor Receives Grant to Develop Crohn’s Disease Treatment
Associate professor Scott Kachlany, PhD, of the Rutgers School of Dental Medicine Department of Oral Biology has received a two-year, $621,403 grant from.
Industry News
Periodontitis Bacterium May Hold the Cure for Leukemia
Actinobacillus actinomycetemcomitans causes periodontal disease. But it also produces a protein that can be used to kill leukemia cells in animals, according to.
